By Elizabeth Powers, Charles Beever, Rick Edmunds, and Jay Kumar
The world’s largest pharmaceutical companies are attempting to reposition their go-to-market capabilities in the face of the rapidly changing healthcare...
Transforming Pharma's Commercial Capabilities to Drive Maximum Value
Large pharmaceutical companies need to accelerate their changing competitive strategies, commercial capabilities, and organizational models to respond adequately to new market conditions. To maximize the value of products, consulting firm Booz Allen proposes aligning commercial operations along three distinct businesses, which cut across specialty and primary care segmentation and which are differentiated based on competitive strategies.